Skip to main content
Caplight Logo









Beijing Wuhe Boao Pharmaceutical Co., Ltd.

Beijing Wuhe Boao Pharmaceutical Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttp://wehandbio.com/

Last Round

Series B

Extension

Sep 1, 2025

Est. Valuation

$562.09M

Total Funding Raised

$216.56M

Company Overview

Beijing Wuhe Boao Pharmaceutical Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B Extension round in September 2025.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. is a biopharmaceutical company that develops natural drug innovations and advanced drug delivery systems for the treatment of metabolic disorders, malignant tumors, and inflammatory-immune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Comparables

Compare Beijing Wuhe Boao Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hua Medicine
80%
Luye Pharma Group
76%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionSep 1, 2025
Series CNov 4, 2024
Series BDec 24, 2020
Series ASep 1, 2015
Series A ExtensionJun 1, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Investors

Notable investors and investment history

Beijing Wuhe Boao Pharmaceutical Co., Ltd. investors
InvestorRounds
Cathay CapitalSeries B, Series B Extension
Northern Light Venture CapitalSeries B Extension, Series A Extension
Lang Sheng InvestmentSeries B Extension
Cowin CapitalSeries B Extension, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2025

    $63M round with Cathay Capital and Cowin Capital

Book a demo to see all signals

For institutional investors. Book with your work email.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Beijing Wuhe Boao Pharmaceutical Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.

Is Beijing Wuhe Boao Pharmaceutical Co., Ltd. a public or private company?

Beijing Wuhe Boao Pharmaceutical Co., Ltd. is a private company.

What is the current stock price of Beijing Wuhe Boao Pharmaceutical Co., Ltd.?

Beijing Wuhe Boao Pharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Beijing Wuhe Boao Pharmaceutical Co., Ltd. worth (valuation)?

Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s valuation is estimated at $562.1M based on funding round data.

Can I buy Beijing Wuhe Boao Pharmaceutical Co., Ltd. stock?

Beijing Wuhe Boao Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s last funding round?

Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s most recent funding round was Series B Extension on September 1, 2025.

Who are the main investors in Beijing Wuhe Boao Pharmaceutical Co., Ltd.?

Key investors in Beijing Wuhe Boao Pharmaceutical Co., Ltd. include Cathay Capital, Northern Light Venture Capital, Lang Sheng Investment, Cowin Capital.

Will Beijing Wuhe Boao Pharmaceutical Co., Ltd. IPO soon?

No public IPO plans have been announced for Beijing Wuhe Boao Pharmaceutical Co., Ltd..

How can I track Beijing Wuhe Boao Pharmaceutical Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Beijing Wuhe Boao Pharmaceutical Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range2
Year Founded2010
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?